You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secukinumab

Showing 26 - 50 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ichthyosis, Autosomal Recessive Congenital Ichthyosis, Lamellar Ichthyosis Trial in Chicago, New York (Secukinumab, Placebo)

Completed
Has Results
  • Ichthyosis
  • +5 more
  • Secukinumab
  • Placebo
  • Chicago, Illinois
  • +1 more
Aug 2, 2021

Alopecia Areata Trial in New York (Secukinumab, Placebo)

Terminated
Has Results
  • Alopecia Areata
  • Secukinumab
  • Placebo
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 16, 2021

Psoriasis Trial in Athens (etanercept, ustekinumab, cyclosporine)

Recruiting
  • Psoriasis
  • Athens, Greece
    Attikon Hospital
Mar 28, 2022

Psoriatic Arthritis Trial in Hong Kong (Secukinumab, Placebo)

Recruiting
  • Psoriatic Arthritis
  • Secukinumab
  • Placebo
  • Hong Kong, Hong Kong
    Department of Medicine and Therapeutics
Jan 27, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Psoriatic Arthritis Trial in Worldwide (Secukinumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Secukinumab
  • Placebo
  • Birmingham, Alabama
  • +80 more
Oct 12, 2022

Psoriasis Trial in San Francisco (Secukinumab)

Completed
Has Results
  • Psoriasis
  • Secukinumab
  • San Francisco, California
    UCSF Psoriasis and Skin Treatment Center
Aug 31, 2020

Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial in Worldwide (Bimekizumab, Secukinumab, Placebo)

Active, not recruiting
Has Results
  • Chronic Plaque Psoriasis
  • Moderate to Severe Chronic Plaque Psoriasis
  • Santa Ana, California
  • +76 more
Jan 25, 2023

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Secukinumab
  • +6 more
  • Brussels, Belgium
  • +18 more
Dec 5, 2022

Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Birmingham, Alabama
  • +7 more
Sep 19, 2022

Psoriatic Arthritis, Axial Spondyloarthritis, Enthesitis Trial in Worldwide (Secukinumab, Secukinumab Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • +2 more
  • Secukinumab
  • Secukinumab Placebo
  • Plovdiv, Bulgaria
  • +54 more
Apr 7, 2021

Psoriasis, Metabolic Syndrome Trial in Verona (Secukinumab, Methotrexate)

Not yet recruiting
  • Psoriasis
  • Metabolic Syndrome
  • Verona, Italy
    University of Verona
Jul 8, 2020

Tendinopathy Trial in Worldwide (secukinumab, Placebo)

Completed
Has Results
  • Tendinopathy
  • secukinumab
  • Placebo
  • Phoenix, Arizona
  • +11 more
Oct 7, 2021

Hidradenitis Suppurativa Trial in Worldwide (secukinumab, Placebo)

Active, not recruiting
  • Hidradenitis Suppurativa
  • secukinumab
  • Placebo
  • Birmingham, Alabama
  • +110 more
Jan 30, 2022

Psoriatic Arthritis Trial in Liverpool (Secukinumab)

Completed
  • Psoriatic Arthritis
  • Secukinumab
  • Liverpool, United Kingdom
    Aintree University Hospitals NHS Foundation Trust
Apr 7, 2020

Non-radiographic Spondyloarthritis Trial in Worldwide (Secukinumab, Placebo)

Completed
Has Results
  • Non-radiographic Spondyloarthritis
  • Secukinumab
  • Placebo
  • Birmingham, Alabama
  • +138 more
Apr 4, 2022

Ankylosing Spondyloarthritis Trial in Worldwide (Secukinumab, Placebo)

Completed
Has Results
  • Ankylosing Spondyloarthritis
  • Secukinumab
  • Placebo
  • Hefei, Anhui, China
  • +43 more
Dec 4, 2020

Pyoderma Gangrenosum Trial in Munich (Secukinumab)

Unknown status
  • Pyoderma Gangrenosum
  • Secukinumab
  • Munich, Germany
    Technical University of Munich
Feb 17, 2020

Papulopustular Rosacea Trial in Redwood City (Secukinumab)

Completed
Has Results
  • Papulopustular Rosacea
  • Secukinumab
  • Redwood City, California
    Stanford Dermatology
Jan 17, 2020

Psoriasis Trial in Worldwide (risankizumab, secukinumab)

Completed
Has Results
  • Psoriasis
  • Glendale, Arizona
  • +60 more
Jun 21, 2021

Lupus Nephritis Trial in Worldwide (secukinumab)

Recruiting
  • Lupus Nephritis
  • secukinumab
  • Birmingham, Alabama
  • +215 more
Nov 16, 2022

Axial Psoratic Arthritis Trial in Worldwide (Secukinumab, Secukinumab and Placebo)

Completed
Has Results
  • Axial Psoratic Arthritis
  • Secukinumab
  • Secukinumab and Placebo
  • Brussels, Belgium
  • +93 more
Sep 9, 2020

Cosentyx (Secukinumab) in Psoriasis Patients

Completed
  • Psoriasis Vulgaris
  • Secukinumab
  • Lubeck, Schleswig-Holstein, Germany
    University Clinic Schleswig-Holstein
Aug 15, 2019

Atopic Dermatitis Trial in New York (Secukinumab, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Secukinumab
  • Placebo
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 23, 2019

Without the Initial Loading Dose in Patients With Psoriasis

Completed
  • Psoriasis Vulgaris
  • Secukinumab
  • Verona, Italy
    University of Verona
Apr 12, 2019